Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance
- PMID: 17699177
- PMCID: PMC1955017
- DOI: 10.1136/hrt.2007.127563
Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance
Abstract
This NICE technology appraisal guidance on cardiac resynchronisation therapy provides additional treatment options for some of the groups of people covered in the earlier guidance on implantable cardioverter defibrillators.
Conflict of interest statement
Competing interests: None declared.
References
-
- National Institute for Health and Clinical Excellence (NICE) NICE technology appraisal guidance 120. Cardiac resynchronisation therapy for the treatment of heart failure. May 2007. Available at http://guidance.nice.org.uk/TA120/niceguidance/pdf/English (accessed 17 July 2007)
-
- National Institute for Health and Clinical Excellence (NICE) NICE technology appraisal guidance 95. Implantable cardioverter defibrillators for arrhythmias: review of technology appraisal 11. January 2006. Available at http://guidance.nice.org.uk/TA95/guidance/pdf/English (accessed 17 July 2007)
-
- Bristow M R, Saxon L A, Boehmer J, Krueger S, Kass D A, De Marco T, Carson P, DiCarlo L, DeMets D, White B G, DeVries D W, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators Cardiac resynchronisation therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 20043502140–2150. - PubMed
-
- Cleland J G, Daubert J C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. Cardiac Resynchronization‐Heart Failure (CARE‐HF) Study Investigators The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 20053521539–1549. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical